내시경용 AI 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global AI in endoscopy market size is expected to reach USD 25.42 Billion in 2034 from USD 3.31 Billion in 2025, growing at a CAGR of 25.42% during 2026-2034.The AI in endoscopy market is experiencing a paradigm shift, fueled by the integration of artificial intelligence technologies that enhance diagnostic accuracy and procedural efficiency. As healthcare systems worldwide strive to improve patient outcomes while managing costs, AI-driven solutions are emerging as indispensable tools in the realm of endoscopic procedures. The ability of AI algorithms to analyze vast amounts of imaging data in real-time allows for the early detection of abnormalities, significantly improving the chances of successful interventions. This trend is particularly relevant in the context of rising incidences of gastrointestinal disorders, where timely diagnosis is critical.

The continuous evolution of machine learning and deep learning techniques is propelling advancements in AI applications for endoscopy. These technologies enable the development of sophisticated image recognition systems that can assist clinicians in identifying polyps, tumors, and other pathological conditions with unprecedented precision. Furthermore, the integration of AI with augmented reality and robotic-assisted endoscopy is set to revolutionize procedural approaches, enhancing the capabilities of healthcare professionals and improving patient experiences. As the technology matures, the potential for AI to facilitate personalized treatment plans based on individual patient data is becoming increasingly viable, paving the way for more targeted and effective interventions.

Moreover, the regulatory landscape is evolving to accommodate the rapid advancements in AI technologies within the medical field. As healthcare providers seek to adopt AI-driven endoscopic solutions, collaboration between technology developers and regulatory bodies will be essential to ensure safety and efficacy. The growing body of clinical evidence supporting the benefits of AI in endoscopy is likely to accelerate adoption rates, as healthcare institutions recognize the value of integrating these technologies into their practices. In conclusion, the AI in endoscopy market is set for remarkable growth, driven by technological innovation, improved patient outcomes, and a commitment to advancing healthcare delivery.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type of Endoscopy

• Gastrointestinal Endoscopy
• Urological Endoscopy
• Respiratory Endoscopy
• Colonoscopy
• Other Types

By Component

• AI-Powered Devices
• Software
• Services

By Type of CAD

• CADx
• CADe

By End Use

• Hospitals
• Specialty Clinics
• Other End Users

COMPANIES PROFILED

• AI Medical Service Inc., Ambu A/S, Boston Scientific Corporation, CONMED Corporation, Cosmo Intelligent Medical Devices, Erbe Elektromedizin GmbH, Fujifilm Holdings Corporation, Hoya Corporation (PENTAX Medical), Intuitive Surgical, Inc., Iterative Health, KARL STORZ SE & Co. KG, MAGENTIQ EYE Ltd., Medtronic, Olympus Corporation (Odin Vision / EndoAid), Richard Wolf GmbH, Smith & Nephew plc, Stryker, Wision AI Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AI IN ENDOSCOPY MARKET: BY TYPE OF ENDOSCOPY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type Of Endoscopy
• 4.2. Gastrointestinal Endoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Urological Endoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Respiratory Endoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Colonoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AI IN ENDOSCOPY MARKET: BY COMPONENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Component
• 5.2. AI-Powered Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AI IN ENDOSCOPY MARKET: BY TYPE OF CAD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type Of Cad
• 6.2. CADx Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CADe Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AI IN ENDOSCOPY MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AI IN ENDOSCOPY MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type Of Endoscopy
  • 8.2.2 By Component
  • 8.2.3 By Type Of Cad
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type Of Endoscopy
  • 8.3.2 By Component
  • 8.3.3 By Type Of Cad
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type Of Endoscopy
  • 8.4.2 By Component
  • 8.4.3 By Type Of Cad
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type Of Endoscopy
  • 8.5.2 By Component
  • 8.5.3 By Type Of Cad
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type Of Endoscopy
  • 8.6.2 By Component
  • 8.6.3 By Type Of Cad
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AI IN ENDOSCOPY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AI Medical Service Inc
  • 10.2.2 Ambu A/S
  • 10.2.3 Boston Scientific Corporation
  • 10.2.4 CONMED Corporation
  • 10.2.5 Cosmo Intelligent Medical Devices
  • 10.2.6 Erbe Elektromedizin GmbH
  • 10.2.7 Fujifilm Holdings Corporation
  • 10.2.8 Hoya Corporation (PENTAX Medical)
  • 10.2.9 Intuitive SurgicalInc
  • 10.2.10 Iterative Health
  • 10.2.11 KARL STORZ SE & Co. KG
  • 10.2.12 MAGENTIQ EYE Ltd
  • 10.2.13 Medtronic
  • 10.2.14 Olympus Corporation (Odin Vision / EndoAid)
  • 10.2.15 Richard Wolf GmbH
  • 10.2.16 Smith & Nephew Plc
  • 10.2.17 Stryker
  • 10.2.18 Wision AI Ltd